Appointment booking for Dr. Rebecca Littaua, MD is currently not available.Dr. Rebecca Littaua, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Rebecca Littaua, MD (she/her) is a Infectious Disease Doctor in Hopewell, VA with over 19 years of experience. What is your opinion of Dr. Rebecca Littaua, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 19 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Rebecca Littaua, MD has received over $2,203 which includes payments from the following companies:
$355.12 from Novo Nordisk Inc
$300.00 from COMSORT, Inc
$239.66 from Amgen Inc.
$222.71 from Takeda Pharmaceuticals America, Inc.
$197.49 from Allergan Inc.
$114.00 from Amarin Pharma Inc.
$109.36 from Horizon Pharma plc
$102.19 from Edwards Lifesciences Corporation
$100.45 from Janssen Pharmaceuticals, Inc
$92.29 from ViiV Healthcare Company
$80.77 from Gilead Sciences Inc
$76.78 from Novartis Pharmaceuticals Corporation
$72.04 from Pfizer Inc.
$53.04 from Theravance Biopharma Inc.
$27.29 from Cubist Pharmaceuticals Inc
$26.95 from Merck Sharp & Dohme Corporation
$22.23 from E.R. Squibb & Sons, L.L.C.
$10.85 from Vyera Pharmaceuticals, LLC
Payments received by Dr. Rebecca Littaua, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!